Skip to main content

Immunocore Holdings plc

IMCR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001671927

No open-market purchases or sales by Immunocore Holdings plc insiders were filed in the last 90 days; 135 institutions reported holding it in 13F filings for Q2 2026, worth $1.65B in total; no superinvestor holds it.

13F holders, Q2 2021

Institutional positions in Immunocore Holdings plc as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
45
+4 vs. Q1 2021
Shares held
14.4M
+272.5K (+1.9%) vs. Q1 2021
Total value
$561.1M
−$36.7M (−6.1%) vs. Q1 2021
New holders
13
10 more added
Sold out
9
12 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 45 institutions
Q1 2021: 41 institutionsQ2 2021: 45 institutionsQ3 2021: 47 institutionsQ4 2021: 49 institutionsQ1 2022: 57 institutionsQ2 2022: 66 institutionsQ3 2022: 86 institutionsQ4 2022: 104 institutionsQ1 2023: 109 institutionsQ2 2023: 120 institutionsQ3 2023: 125 institutionsQ4 2023: 133 institutionsQ1 2024: 149 institutionsQ2 2024: 139 institutionsQ3 2024: 130 institutionsQ4 2024: 116 institutionsQ1 2025: 117 institutionsQ2 2025: 134 institutionsQ3 2025: 133 institutionsQ4 2025: 149 institutionsQ1 2026: 142 institutionsQ2 2026: 135 institutions
Value heldQ2 2021: $561.1M
Q1 2021: $597.8MQ2 2021: $561.1MQ3 2021: $617.4MQ4 2021: $642.4MQ1 2022: $590.1MQ2 2022: $784.5MQ3 2022: $1.25BQ4 2022: $1.73BQ1 2023: $1.61BQ2 2023: $2.12BQ3 2023: $1.92BQ4 2023: $2.56BQ1 2024: $2.68BQ2 2024: $1.46BQ3 2024: $1.41BQ4 2024: $1.34BQ1 2025: $1.40BQ2 2025: $1.50BQ3 2025: $1.79BQ4 2025: $1.79BQ1 2026: $1.58BQ2 2026: $1.65B
Institutions holding IMCR and their total value by quarter
QuarterHoldersValue
Q2 2026135$1.65B
Q1 2026142$1.58B
Q4 2025149$1.79B
Q3 2025133$1.79B
Q2 2025134$1.50B
Q1 2025117$1.40B
Q4 2024116$1.34B
Q3 2024130$1.41B
Q2 2024139$1.46B
Q1 2024149$2.68B
Q4 2023133$2.56B
Q3 2023125$1.92B
Q2 2023120$2.12B
Q1 2023109$1.61B
Q4 2022104$1.73B
Q3 202286$1.25B
Q2 202266$784.5M
Q1 202257$590.1M
Q4 202149$642.4M
Q3 202147$617.4M
Q2 202145$561.1M
Q1 202141$597.8M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding Immunocore Holdings plc; share changes are against Q1 2021.

Institutions holding IMCR in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Baker Bros. Advisors LP2,520,730$98.4M0.43%00.0%Unchanged
Rock Springs Capital Management LP2,394,785$93.5M1.85%+102,500+4.5%Added
FMR LLC1,231,844$48.1M0.00%−189,293−13.3%Reduced
RTW Investments, LP1,245,532$47.9M0.72%00.0%Unchanged
BlackRock Inc.1,079,926$42.2M0.00%−1990.0%Reduced
General Atlantic LLC950,000$37.1M0.26%00.0%Unchanged
Avidity Partners Management LP601,000$23.5M0.63%+51,000+9.3%Added
Bill & Melinda Gates Foundation576,923$23.0M3.53%00.0%Unchanged
Bain Capital Public Equity Management II, LLC474,554$18.5M0.79%+173,683+57.7%Added
Perceptive Advisors LLC400,000$15.6M0.20%00.0%Unchanged
Price T Rowe Associates Inc367,304$14.3M0.00%−20,608−5.3%Reduced
Deerfield Management Company, L.P. (Series C)360,966$14.1M0.25%+189,058+110.0%Added
Thrivent Financial for Lutherans348,814$13.6M0.03%+28,562+8.9%Added
Wellington Management Group LLP291,512$11.4M0.00%+44,154+17.9%Added
HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse)277,754$10.8M0.11%−1,826−0.7%Reduced
Artal Group S.A.200,000$7.81M0.18%00.0%Unchanged
Principal Financial Group Inc177,105$6.92M0.00%+53,533+43.3%Added
Tybourne Capital Management (HK) Ltd138,192$5.40M0.11%00.0%Unchanged
Millennium Management LLC103,121$4.03M0.01%−100,534−49.4%Reduced
Massachusetts Financial Services Co97,226$3.80M0.00%−276−0.3%Reduced
Rhenman & Partners Asset Management AB90,000$3.52M0.24%+90,000New
Point72 Asset Management, L.P.72,900$2.85M0.01%+72,900New
Samsara BioCapital, LLC64,000$2.50M0.33%−16,000−20.0%Reduced
Alps Advisors Inc57,273$2.24M0.02%+57,273New
Omega Fund Management, LLC51,535$2.01M0.23%00.0%Unchanged
Citadel Advisors LLC51,310$2.00M0.00%−126−0.2%Reduced
Marshall Wace North America L.P.25,144$982.0K0.00%−36,614−59.3%Reduced
TD Asset Management Inc27,506$900.0K0.00%00.0%Unchanged
Legal & General Group Plc19,091$725.0K0.00%+19,091New
J. Goldman & Co LP16,685$652.0K0.04%+16,685New
Bank of New York Mellon Corp12,896$504.0K0.00%+12,896New
UBS Group AG12,014$469.0K0.00%+341+2.9%Added
ETF Managers Group, LLC13,162$464.0K0.01%−49−0.4%Reduced
Victory Capital Management Inc9,528$372.0K0.00%−472−4.7%Reduced
Boothbay Fund Management, LLC6,056$236.0K0.01%+6,056New
Geode Capital Management, LLC5,997$234.0K0.00%+5,997New
Virtus ETF Advisers LLC5,634$220.0K0.09%+5,634New
Zurcher Kantonalbank (Zurich Cantonalbank)3,864$151.0K0.00%+3,864New
Leonteq Securities AG1,000$39.0K0.00%+1,000New
State of Wyoming212$8.00K0.01%+212New
Bank of America Corp145$6.00K0.00%+45+45.0%Added
Advisor Group Holdings, Inc.129$5.00K0.00%+7+5.7%Added
Morgan Stanley20$1.00K0.00%−15,187−99.9%Reduced
Harbour Investments, Inc.25$1.00K0.00%00.0%Unchanged
Point72 Hong Kong Ltd3$00.00%+3New
Invesco Ltd.0$00.00%−150,658−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−36,000−100.0%Sold out
Alyeska Investment Group, L.P.0$00.00%−35,000−100.0%Sold out
Pinz Capital Management, LP0$00.00%−18,700−100.0%Sold out
Caas Capital Management LP0$00.00%−15,000−100.0%Sold out
Anson Funds Management LP0$00.00%−10,000−100.0%Sold out
Zimmer Partners, LP0$00.00%−10,000−100.0%Sold out
Laurion Capital Management LP0$00.00%−5,000−100.0%Sold out
Rokos Capital Management LLP0$00.00%−500−100.0%Sold out